Basalo, Marlon G.

HRN: 28-46-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2026
CEFTAZIDIME 1GM (VIAL)
01/26/2026
02/02/2026
IVTT
2g
Q8H
CAP-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines